5-Fluorouracil (5Fu)
Efficacy of dermabrasion along with topical 1% 5-fluorouracil in 25 patients of vitiligo
... with 5 fluorouracil can be used as a simple office procedure, in repigmenting focal and to a lesser extent generalized stable vitiligo, which is very economical & brings early repigmentation without any ...
85
DEVELOPMENT AND IN VITRO EVALUATION OF 5 FLUOROURACIL NANOPARTICLES BY SALTING OUT TECHNIQUE
... Pancreatic cancer is the ninth more prevalent and challenging to treat. Several formulations are now available for the treatment of pancreatic cancer and 5-fluorouracil (5-FU) is one of the most ...
6
Mechanism of 5 Fluorouracil Induced Apoptosis on Cultured Corneal Endothelial Cells
... surgery, 5-FU was introduced as an ad- junct agent administered by repeated subconjunctival injections after trabeculectomy to inhibit the proliferation of fibroblasts [4] ...of 5-FU up to a total dose of ...
11
Dermabration followed by topical 5% 5-fluorouracil and autologous melanocyte transplantation in stable vitiligo
... The selected lesion was anesthetized with local application of eutectic mixture of local anesthetics (EMLA) patch sixty minutes preoperatively. Electrical or mechanical dermabrader of appropriate size was used to abrade ...
5
Preparation of 5-fluorouracil nanoparticles by supercritical antisolvents for pulmonary delivery
... of 5-fluorouracil (5-FU) ...of 5-FU in order to deliver it directly to the respiratory ...of 5-FU precipitated from methanol-dichloromethane 50:50 had a mean particle size of 248 ...six ...
8
Controlled release of 5-fluorouracil and progesterone from magnetic nanoaggregates
... The nanoaggregates that we proposed are advantageous by their facile and organic solvent free method of preparation, and lack of toxic degradation products which comes from polymeric degradation. In addition, these ...
23
Optimized synthesis of glycyrrhetinic acid-modified chitosan 5-fluorouracil nanoparticles and their characteristics
... and 5-FU and conjugating 5-FU onto the GA-CTS ...=5:1, 5-FU:CTS weight ratio =1:1, TPP concentration ...the 5-FU group, but the maximum concentration (C max ) was ...
16
ENTERIC COATED 5-FLUOROURACIL CAPSULES DESIGNED TO ACHIEVE INTESTINAL TARGETING
... 2.2. Preparation of 5-Fluorouracil granules Different batches of matrix granules of 5- fluorouracil were formulated by wet granulation method. All ingredients were weighed on digital weighing ...
9
Cardiotoxicity of 5-fluorouracil and capecitabine in Chinese patients: a prospective study
... drug 5-fluorouracil (5-FU) and its oral prodrug capecitabine have been reported to induce adverse cardiac effects, despite being considered as tol- erable in most cases ...[2–4]. 5-FU and ...
7
Self-assembling peptide nanofibers containing phenylalanine for the controlled release of 5-fluorouracil
... drug 5-fluorouracil (5-FU) at basic pH. As 5-FU contains the aromatic pyrimidine ring, RADA-F6 system is suitable for entrapping an aromatic drug due to effective π–π stacking with ...
12
Bioavailability Study of Oral 5-Fluorouracil in Colorectal Cancer Patients.
... of 5-Fluorouracil (5-FU) when given with skimmed milk in colorectal cancer ...Oral 5-FU (500 mg/m 2 ) was administered with skimmed milk (250 ml) to colorectal cancer ...administration. ...
10
Hemostatic absorbable gelatin sponge loaded with 5-fluorouracil for treatment of tumors
... Results: 5-FU-HAGS (hemostatic absorbable gelatin sponge loaded with 5-fluorouracil) was successfully produced with controlled release of the content and was reproducibly suitable for local tumor ...
8
A Hypothesis Concerning the Effect of Schedule on the Pattern of 5 Fluorouracil Toxicity
... Up to the present time most initial anti-cancer chemotherapeutic regimes have been empirically designed, with several different types of schedule being compared. It is not unusual for a different pattern of organ ...
6
Effects of plasma concentrations of 5-fluorouracil on long-term survival after treatment with a definitive 5-fluorouracil/cisplatin-based chemoradiotherapy in Japanese patients with esophageal squamous cell carcinoma
... Originally, 5-FU was administered alone as a bolus, but more recently, it is being administered with biomodulating agents and/or through continuous infusion ...to 5-FU improves its cytotoxic activity and ...
7
Investigation of the Electrochemical Interaction Behavior of DNA with 5-Fluorouracil Derivatives
... [13]. 5-Fluorouracil (5-FU) has been increasingly employed alone or in therapy combined with various cytotoxic drugs and hormones in the treatment of several tumors, such as breast, colorectal and ...
10
RGS17 inhibits tumorigenesis and improves 5-fluorouracil sensitivity in nasopharyngeal carcinoma
... into a six-well plate. After attachment overnight, 2.5 mg/L 5-fluorouracil (5-FU) was added at the concentrations indi- cated, and the cells were incubated for 24 hours. All cells, including the ...
10
Synthesis and Antitumor Evaluation of Some 5 fluorouracil Derivatives
... of 5-FU are greatly limited by its short plasma half-life, poor tumor affinity, myelosuppression, and strong intestinal ...which 5-FU is conjugated with several carriers including glucose, peptides, and ...
6
5 Fluorouracil encapsulated silver nanoparticle for effective anticancer drug delivery
... 2013). 5-Fluorouracil is widely used in the treatment of cancer and effective against solid tumors, mainly has a better therapeutic effect on et ...However, 5-Fu has heavy toxic side effects, little ...
5
Formulation and Optimization of Controlled Release 5-Fluorouracil Tablets for Colonic Delivery
... of 5-fluorouracil at the colonic ...the 5 hr lag time ...for 5-Fluorouracil delivery at the colonic site was able to achieve a sufficient lag time and controlled drug ...
5
POLYGENIC CONTROL OF THE TERATOGENICITY OF 5-FLUOROURACIL IN MICE
... Ten days later (2.40 hours after discovery of the vaginal plug), the females were given an intraperitoneal injection of 0.25 ml of a water solution of 5-fluorouracil. Pregnant f[r] ...
17